Mass Spectrometry‐Based Proteomics Technologies to Define Endogenous Protein‐Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases
Mass Spectrometry Reviews · 2026-07 · 45 (4) · 714-744
DOI: 10.1002/mas.21926 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 09.02.2025. Verfasst von Clinton Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Biophysics, University of California, Irvine, Irvine, California, USA. Hauptthemen laut MEDLINE: Proteomics, Mass Spectrometry, Virus Diseases, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 438 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, This work was supported by National Institutes of Health grants R35GM145249 to L.H., National Institute of General Medical Sciences.
Abstract (Originalsprache)
An intricate network of protein assemblies and protein‐protein interactions (PPIs) underlies nearly every biological process in living systems. The organization of these cellular networks is highly dynamic and intimately tied to the genomic and proteomic landscapes of a cell. Disruptions in normal PPIs can impair cellular functions and contribute to the development of human diseases. In recent years, targeting PPIs has emerged as an attractive strategy for drug discovery. Consequently, the identification and characterization of endogenous PPIs—those occurring naturally under physiological conditions—has become crucial for unraveling the molecular mechanisms driving human pathology and for laying the groundwork for novel diagnostics and therapeutics. Owing to numerous technological advancements, mass spectrometry (MS)‐based proteomics has transformed the study of PPIs at the systems‐level. This review focuses on proteomics approaches that enable the characterization of physiologically relevant endogenous interactions, spanning complex‐centric to structure‐centric analyses. Additionally, their applications to define native PPIs in the contexts of cancer and viral infectious diseases is highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology & Biophysics, University of California, Irvine, Irvine, California, USA.
- Department of Bioengineering, University of California, San Francisco, San Francisco, California, USA.
- Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, California, USA.
- J. David Gladstone Institutes, San Francisco, California, USA.
Förderung
- NIGMS NIH HHS
- This work was supported by National Institutes of Health grants R35GM145249 to L.H.
- National Institute of General Medical Sciences
Zitieren
APA
Yu, C., Adavikolanu, R., Kaake, R. M., & Huang, L. (2026). Mass Spectrometry‐Based Proteomics Technologies to Define Endogenous Protein‐Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases. Mass Spectrometry Reviews, 45(4), 714-744. https://doi.org/10.1002/mas.21926
Vancouver
Yu C, Adavikolanu R, Kaake RM, Huang L. Mass Spectrometry‐Based Proteomics Technologies to Define Endogenous Protein‐Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases. Mass Spectrometry Reviews. 2026;45(4):714-744. doi:10.1002/mas.21926
BibTeX
@article{Yu2026,
author = {Yu, Clinton and Adavikolanu, Rithika and Kaake, Robyn M and Huang, Lan},
title = {Mass Spectrometry‐Based Proteomics Technologies to Define Endogenous Protein‐Protein Interactions and Their Applications to Cancer and Viral Infectious Diseases},
journal = {Mass Spectrometry Reviews},
year = {2026},
volume = {45},
number = {4},
pages = {714--744},
doi = {10.1002/mas.21926}
}
EUVIMED